Progyny Inc.

**Signal Note: RA Capital initiates in PGNY** RA Capital's $2.5M entry into Progyny signals confidence in the fertility benefits management platform's secular growth tailwinds as employer adoption of reproductive health coverage expands post-Dobbs decision. The position size is modest relative to RA's typical deployment, suggesting conviction in market dynamics rather than near-term clinical/regulatory catalysts, with upside likely dependent on normalized fertility utilization rates and margin expansion as the platform scales.